Bimin Li

Jiangxi Provincial Key Laboratory Of Digestive Diseases
Nanchang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

GPX8+ cancer-associated fibroblast-derived lactate contributes to lenvatinib resistance by facilitating BRPF1 expression through histone H3 lysine 18 lactylation in hepatocellular carcinoma.

GPX8+ cancer-associated fibroblast-derived lactate contributes to lenvatinib resistance by facilitating BRPF1 expression through histone H3 lysine 18 lactylation in hepatocellular carcinoma.

Journal: Oncogene

Published: August 01, 2025

Identifying Low-Risk Patients with Cirrhosis and Acute Gastrointestinal Bleeding That May Not Require Urgent Endoscopy.

Identifying Low-Risk Patients with Cirrhosis and Acute Gastrointestinal Bleeding That May Not Require Urgent Endoscopy.

Journal: Advances in therapy

Published: June 19, 2025

FBXO22 promotes hepatocellular carcinoma progression via paracrine myo‑inositol‑induced M2‑type polarization of macrophages.

FBXO22 promotes hepatocellular carcinoma progression via paracrine myo‑inositol‑induced M2‑type polarization of macrophages.

Journal: International journal of molecular medicine

Published: May 07, 2025

Machine learning based CAGIB score predicts in-hospital mortality of cirrhotic patients with acute gastrointestinal bleeding.

Machine learning based CAGIB score predicts in-hospital mortality of cirrhotic patients with acute gastrointestinal bleeding.

Journal: NPJ digital medicine

Published: February 27, 2025

MFAP4 Deficiency Attenuates Liver Fibrosis by Regulating Hepatic Stellate Cell Fate Through Inhibition of the FAK/PI3K/NFκB Signaling Pathway.

MFAP4 Deficiency Attenuates Liver Fibrosis by Regulating Hepatic Stellate Cell Fate Through Inhibition of the FAK/PI3K/NFκB Signaling Pathway.

Journal: Cellular and molecular gastroenterology and hepatology

Published: December 03, 2024

Ursolic acid alleviates liver fibrosis by regulating Hepatic stellate cell activation via the Notch3/NOX4 pathway.

Ursolic acid alleviates liver fibrosis by regulating Hepatic stellate cell activation via the Notch3/NOX4 pathway.

Journal: Chemico-biological interactions

Published: November 21, 2024

CircMALAT1 promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma via the miR-512-5p/VCAM1 axis.

CircMALAT1 promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma via the miR-512-5p/VCAM1 axis.

Journal: Acta biochimica et biophysica Sinica

Published: October 28, 2024

Impact of thrombocytopenia on failure of endoscopic variceal treatment in cirrhotic patients with acute variceal bleeding.

Impact of thrombocytopenia on failure of endoscopic variceal treatment in cirrhotic patients with acute variceal bleeding.

Journal: Therapeutic advances in gastroenterology

Published: August 19, 2024

Impact of peptic ulcer bleeding on the in-hospital outcomes of cirrhotic patients with acute gastrointestinal bleeding: an international multicenter study.

Impact of peptic ulcer bleeding on the in-hospital outcomes of cirrhotic patients with acute gastrointestinal bleeding: an international multicenter study.

Journal: Expert review of gastroenterology & hepatology

Published: August 05, 2024

Timing of endoscopy in cirrhotic patients with acute variceal bleeding: protocol of a multicenter randomized controlled trial.

Timing of endoscopy in cirrhotic patients with acute variceal bleeding: protocol of a multicenter randomized controlled trial.

Journal: Therapeutic advances in gastroenterology

Published: June 11, 2024

Routine nasogastric tube placement in patients with small esophageal perforation after endoscopic foreign body removal may be unnecessary: a propensity score matching analysis.

Routine nasogastric tube placement in patients with small esophageal perforation after endoscopic foreign body removal may be unnecessary: a propensity score matching analysis.

Journal: Gastroenterology report

Published: April 12, 2023

Practice guidance for the use of terlipressin for liver cirrhosis-related complications.

Practice guidance for the use of terlipressin for liver cirrhosis-related complications.

Journal: Therapeutic advances in gastroenterology

Published: March 11, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026